Diflorasone diacetate
Appearance
(Redirected from Psorcon)
Clinical data | |
---|---|
Trade names | Psorcon |
AHFS/Drugs.com | Monograph |
MedlinePlus | a602019 |
License data |
|
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.046.872 |
Chemical and physical data | |
Formula | C26H32F2O7 |
Molar mass | 494.532 g·mol−1 |
| |
(what is this?) (verify) |
Diflorasone diacetate is a topical steroid that comes in the form of a cream. It is manufactured by E. Fougera & Co. and is used as an anti-inflammatory and anti-itching agent, like other topical corticosteroids. It is prescribed for psoriasis[1] and atopic dermatitis, among other conditions. With respect to potency, it is regarded as a Class I corticosteroid [of classes I – VII] in the United States.[2]
No long-term animal studies have been done to determine whether diflorasone diacetate could have carcinogenic properties.[citation needed]
Little data is available regarding whether diflorasone diacetate would be present in great enough quantities to cause harm to an infant.[3]
References
[edit]- ^ Shupack JL, Jondreau L, Kenny C, Stiller MJ (1993). "Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis". Dermatology. 186 (2): 129–32. doi:10.1159/000247323. PMID 8428041.
- ^ "Topical Steroids Potency Chart". psoriasis.org.
- ^ "Diflorasone topical". Drugs.com.
External links
[edit]- "Diflorasone diacetate". Drug Information Portal. U.S. National Library of Medicine.